The guidelines emphasize broth microdilution or agar disk diffusion, offering specific incubation time and temperature recommendations for each group. How to Access and Use CLSI M45-Ed3
🔥 Hot now: Cefiderocol breakpoints (Section 5.2) – 47 people annotated this today. 🎮 Play “Zone or Resistant?” – 30-sec MIC challenge. 📈 Trending organism: Carbapenem-resistant A. baumannii – Jump to relevant table. 🧠 Daily Quiz – “What’s the MIC breakpoint for tigecycline vs. S. pneumoniae?” (answers in M45)
Including Vibrio cholerae and Vibrio vulnificus .
is a cornerstone for laboratories dealing with challenging bacterial infections. It provides the necessary framework to ensure that susceptibility results are accurate, reproducible, and actionable. Using the 3rd Edition of CLSI M45 ensures your lab is following the most current, consensus-driven guidelines for patient care. clsi document m45 pdf
Frequently isolated from respiratory cultures, where beta-lactamase production must be monitored. Structure of the CLSI M45 Document
This article provides a comprehensive overview of the CLSI M45 guideline, its importance in clinical settings, and why accessing the latest edition is crucial for accurate susceptibility testing. What is CLSI Document M45?
to input the specific M45 interpretive criteria for disk diffusion, particularly if not using standard M100 breakpoints. Validation: The guidelines emphasize broth microdilution or agar disk
Disclaimer: This article is for informational purposes. Always refer to the latest, official CLSI documents for clinical laboratory practices.
Includes Corynebacterium spp., Micrococcus spp., and Abiotrophia spp./ Granulicatella spp..
Often intrinsically resistant to vancomycin. 3. Environmental and Opportunistic Pathogens 📈 Trending organism: Carbapenem-resistant A
The document has undergone several revisions:
The M45 guideline is not a static document. The CLSI is actively working on a , with discussions and data review well underway. Based on meeting minutes, the final draft for the 4th edition was targeted for February 2024 to allow for publication in 2025. Emerging data, such as that for Aerococcus spp., are being used to propose changes to the guideline. The work to define the precise roles of M45 and M100 is also ongoing, with efforts to develop clear definitions for what constitutes an M100 organism versus an M45 organism.
Often intrinsically resistant to vancomycin, requiring careful therapeutic selection.
The CLSI M45 document is a comprehensive guideline that fills a unique niche in the world of antimicrobial susceptibility testing (AST). While CLSI's primary documents (such as M07 and M100) provide methods for testing common, rapidly growing aerobic bacteria, M45 is designed for the outliers. These are the bacteria that are in a standard clinical laboratory or are fastidious , meaning they have complex nutritional requirements and are difficult to grow and maintain in a culture medium.
A: Some professors receive instructor copies. Ask your course director. Otherwise, many university libraries have CLSI subscriptions.